T 1066/03 (Polymorphic Atorvastatin/WARNER-LAMBERT) of 11.07.2006
- European Case Law Identifier
- ECLI:EP:BA:2006:T106603.20060711
- Date of decision
- 11 July 2006
- Case number
- T 1066/03
- Petition for review of
- -
- Application number
- 96924553.9
- IPC class
- C07D 207/34
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- NOVEL PROCESS FOR THE PRODUCTION OF AMORPHOUS [R-(R*,R*)]-2-(4-FLUOROPHENYL)-BETA,DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1)
- Applicant name
- Warner-Lambert Company LLC
- Opponent name
- Dr. Robert Waldraff
-Patente, Strategien, Märkte- - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b) 1973European Patent Convention Art 83 1973
- Keywords
- Sufficiency of disclosure (no) - undue burden in carrying out the claimed invention - research program
- Catchword
- -
- Cited cases
- T 0737/90
- Citing cases
- T 0777/08
ORDER
For these reasons it is decided that:
The appeal is dismissed.